Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients

Condition:   Hepatitis B Virus (HBV) Interventions:   Biological: T101 Group;   Biological: Placebo Group Sponsor:   Tasly Tianjin Biopharmaceutical Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials